Researchers at the Johns Hopkins Bloomberg School of Public Health found that a slow-growing variant form of Lyme bacteria caused severe symptoms in a mouse model, which may account for the persistent symptoms seen in up to twenty percent of Lyme patients that are not cured by the current Lyme antibiotic regimen.

In addition, they also found that these “persister” Lyme bacteria were resistant to standard single-antibiotic Lyme treatments currently used to treat patients, while a three-antibiotic cocktail eradicated the Lyme bacteria in the mouse model.

Joining me to discuss these findings from a recent study in Discovery Medicine is Ying Zhang, MD, PhD. Dr Zhang is a professor in the Department of Molecular Microbiology and Immunology at the Bloomberg School.

Read the study in Discovery Medicine

Global Lyme Diagnostics has developed a breakthrough test specifically for Lyme Disease


Borrelia burgdorferi spirochetes/CDC

Listen to more podcasts:

Bacteriophages and ‘The Perfect Predator’

Acanthamoeba case in Michigan with Shahzad Mian, M.D.

Cytomegalovirus, the RUSP and the National CMV Foundation

Lyme disease, ticks and the ecology with Richard Ostfeld, PhD

Polio eradication successes and struggles, Unusual infectious disease news

Chronic Wasting Disease and the CIDRAP program

Asian longhorned ticks with Maria Diuk-Wasser, PhD


Intro music: “Rapture” by Ross Bugden